p53 mutants exhibiting enhanced transcriptional activation and altered promoter selectivity are revealed using a sensitive, yeast-based functional assay

Oncogene
Alberto IngaMichael A Resnick

Abstract

Changes in promoter specificity and binding affinity that may be associated with p53 mutations or post-translational modifications are useful in understanding p53 structure/function relationships and categorizing tumor mutations. We have exploited variable expression of human p53 in yeast to identify mutants with novel phenotypes that would correspond to altered promoter selectivity and affinity. The p53 cDNA regions coding for the DNA binding and tetramerization domains were subjected to random PCR mutagenesis and were cloned directly by recombination in yeast into a vector with a GAL1 promoter whose level of expression could be easily varied. p53 variants exhibiting higher than wild type levels of transactivation (supertrans) for the RGC responsive element were identified at low level of p53 protein expression. All the p53 mutants obtained with this screen were located in the DNA binding domain. Two out of 17 supertrans mutants have been found in tumors. Six mutations were in the L1 loop region between amino acids 115 and 124. The transactivation potential of a panel of supertrans p53 mutants on different promoters was evaluated using the p53 responsive elements, RGC, PIG3, p21 and bax. Although all mutants retained some acti...Continue Reading

References

Apr 11, 1992·Nucleic Acids Research·E Schärer, R Iggo
May 8, 1992·Science·S E KernB Vogelstein
Jul 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·T FrebourgS H Friend
Aug 1, 1990·Trends in Genetics : TIG·C HuxleyI Dunham
Apr 25, 1995·Proceedings of the National Academy of Sciences of the United States of America·J M FlamanJ Benhattar
Oct 18, 1995·Molecular and Cellular Biochemistry·C M MalliaB S Beckman
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·R K BrachmannJ D Boeke
May 1, 1996·Genes & Development·L J Ko, C Prives
Aug 2, 1996·Journal of Molecular Biology·T Soussi, P May
Sep 1, 1996·Molecular and Cellular Biology·P FriedlanderM Oren
Feb 7, 1998·Proceedings of the National Academy of Sciences of the United States of America·A N BullockA R Fersht
Jun 25, 1998·Molecular and Cellular Biology·M W FrazierG P Zambetti
Aug 28, 1998·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·U ProskeA Iggo
Oct 9, 1998·Genes & Development·A J Giaccia, M B Kastan
Dec 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·P V NikolovaA R Fersht
Jan 9, 1999·International Journal of Radiation Biology·D W Meek
Mar 27, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·W M Gallagher, R Brown
Apr 17, 1999·Molecular and Cellular Biology·G SelivanovaK G Wiman
May 18, 1999·Journal of the National Cancer Institute·S G SwisherM K Waugh
May 26, 1999·The Journal of Pathology·C Prives, P A Hall
Aug 17, 1999·The EMBO Journal·E SallerR Iggo
Nov 24, 1999·The EMBO Journal·M GostissaG Del Sal
Nov 24, 1999·International Journal of Cancer. Journal International Du Cancer·P O ChappuisR Iggo
Dec 14, 1999·The Journal of Biological Chemistry·M Oren
Jan 5, 2000·Science·B A FosterF Rastinejad

❮ Previous
Next ❯

Citations

Apr 3, 2007·Oncogene·E Kim, W Deppert
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Daniel MenendezMichael A Resnick
Jun 3, 2010·Cold Spring Harbor Perspectives in Biology·Andreas C Joerger, Alan R Fersht
Jul 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paola MontiGilberto Fronza
Mar 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Buyong MaRuth Nussinov
Aug 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Michael A Resnick, Alberto Inga
Jul 22, 2008·Mutation Research·Jean-François MillauRégen Drouin
Jul 6, 2007·Journal of Molecular Biology·Chen Xue FenFarid J Ghadessy
Jan 23, 2014·Human Mutation·Alessandra BisioPaola Monti
Sep 6, 2005·Differentiation; Research in Biological Diversity·Jana SmardováJana Koptíková
Sep 30, 2016·FEMS Yeast Research·Vasundhara SharmaAlberto Inga
Nov 21, 2009·Technology in Cancer Research & Treatment·Uma Chandrachud, Susannah Gal
Feb 2, 2002·Nature Reviews. Molecular Cell Biology·Brian K Kennedy
May 12, 2006·The Journal of Biological Chemistry·Andrew Zupnick, Carol Prives
Sep 17, 2017·Oncotarget·Olivier BillantCécile Voisset
Jun 20, 2012·International Journal of Oncology·Jana JagosovaJana Smardova
Aug 17, 2020·Nucleic Acids Research·Morgan A SammonsMartin Fischer
May 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Coralie FouquetThierry Soussi
Jun 28, 2014·G3 : Genes - Genomes - Genetics·Sarah H LockwoodDavid J Segal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.